Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.735
Delayed Data
As of Mar 27
 +0.0128 / +1.77%
Today’s Change
0.65
Today|||52-Week Range
1.29
+5.00%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Jeong Tae Heum
Chief Financial Officer
Sale1/09/2015188,690$0.92$173.6K-20.11%
Ahn Chang Ho
Director
Sale1/09/2015186,212$0.92$171.3K-20.11%
Jeong Tae Heum
Chief Financial Officer
Buy1/09/2015188,690$0.80$151.0K-20.11%
Ahn Chang Ho
Director
Buy1/09/2015186,212$0.80$149.0K-20.11%
Ahn Chang Ho
Director
Sale6/12/2014136,193$0.99$134.8K-24.28%
Ahn Chang Ho
Director
Buy6/12/2014136,193$0.80$109.0K-24.28%
Mcintosh David Martin
Director
Sale4/14/201499,010$1.01$100.0K-27.23%
Mcintosh David Martin
Director
Buy4/14/2014125,000$0.80$100.0K-27.23%
Ahn Chang Ho
Director
Sale1/08/201580,000$0.90$72.0K-18.33%
Jeong Tae Heum
Chief Financial Officer
Sale1/08/201578,782$0.90$70.9K-18.33%
Page of 2

To view my watchlist

Not a member yet?

Sign up now for a free account